Skip to Content

12 Results Found

  • Article
  • Open Access
2 Citations
5,576 Views
14 Pages

Predicting the Effect of Meropenem Against Klebsiella pneumoniae Using Minimum Inhibitory Concentrations Determined at High Inocula

  • Maria V. Golikova,
  • Kamilla N. Alieva,
  • Elena N. Strukova,
  • Julia R. Savelieva and ,
  • Daria A. Kondratieva,
  • Svetlana A. Dovzhenko,
  • Mikhail B. Kobrin,
  • Vladimir A. Ageevets,
  • Alisa A. Avdeeva and
  • Stephen H. Zinner
  • + 5 authors+ 0 author

Background/Objectives: Assessing antibiotic MICs at high bacterial counts is likely to disclose hidden bacterial resistance and the inoculum effect if present and therefore also reveal potential decreased antibiotic effectiveness. In the current stud...

(This article belongs to the Section Mechanism and Evolution of Antibiotic Resistance)
  • Review
  • Open Access
19 Citations
5,100 Views
16 Pages

The Application of Hollow Fiber Cartridge in Biomedicine

  • Yixuan Hou,
  • Kun Mi,
  • Lei Sun,
  • Kaixiang Zhou and ,
  • Lei Wang,
  • Lan Zhang,
  • Zhenli Liu and
  • Lingli Huang
  • + 3 authors+ 0 author

The hollow fiber cartridge has the advantages of good semi-permeability, high surface area to volume ratio, convenient operation, and so on. Its application in chemical analysis, drug in vitro experiment, hemodialysis, and other fields has been deepl...

  • Article
  • Open Access
2 Citations
4,405 Views
9 Pages

Pharmacokinetic/pharmacodynamic (PKPD) studies of anti-infectives are frequently performed in in vitro infection models where accurate quantification of antibiotic concentrations in bacterial growth media is crucial to establish PK/PD relationships....

(This article belongs to the Section Analysis of Natural Products and Pharmaceuticals)
  • Review
  • Open Access
8 Citations
4,847 Views
16 Pages

In light of rising antimicrobial resistance and a decreasing number of antibiotics with novel modes of action, it is of utmost importance to accelerate development of novel treatment options. One aspect of acceleration is to understand pharmacokineti...

(This article belongs to the Special Issue Pharmacokinetics and Pharmacodynamics of Antibacterial and Antivirulence Drugs)
  • Communication
  • Open Access
4 Citations
3,787 Views
7 Pages

Experimental Validation of a Mathematical Framework to Simulate Antibiotics with Distinct Half-Lives Concurrently in an In Vitro Model

  • Brianna M. Eales,
  • Cole S. Hudson,
  • Iordanis Kesisoglou,
  • Weiqun Wang and ,
  • Michael Nikolaou and
  • Vincent H. Tam
  • + 1 author+ 0 author

16 October 2021

Antimicrobial resistance has been steadily increasing in prevalence, and combination therapy is commonly used to treat infections due to multidrug resistant bacteria. Under certain circumstances, combination therapy of three or more drugs may be nece...

(This article belongs to the Special Issue 10th Anniversary of Antibiotics—Recent Advances in Pharmacodynamics of Antibiotics)
  • Review
  • Open Access
441 Views
15 Pages

The rising prevalence of macrolide and fluoroquinolone resistance in human pathogenic mycoplasmas, such as Mycoplasma pneumoniae and Mycoplasma genitalium, threatens global public health. Mutations in 23S rRNA and quinolone resistance-determining reg...

(This article belongs to the Special Issue Advances in Mycoplasma Research, 2nd Edition)
  • Article
  • Open Access
14 Citations
4,515 Views
12 Pages

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence

  • Inmaculada Lopez-Montesinos,
  • María Milagro Montero,
  • Sandra Domene-Ochoa,
  • Carla López-Causapé and ,
  • Daniel Echeverria,
  • Luisa Sorlí,
  • Nuria Campillo,
  • Sonia Luque,
  • Eduardo Padilla and
  • Juan P. Horcajada
  • + 8 authors+ 3 authors

22 October 2022

This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR) P. aeruginosa infection who developed resistance to ceftazidime-avibactam (CAZ-AVI) with in vitro results of a 7-day hollow-fiber infection model (HFIM) test...

(This article belongs to the Special Issue A Themed Issue in Honor of Professor Jordi Vila—Outstanding Contributions in the Fields of Antimicrobial Resistance)
  • Article
  • Open Access
2 Citations
2,171 Views
13 Pages

13 December 2024

Background: A potential strategy to maintain the efficacy of carbapenems against carbapenemase-producing Klebsiella pneumoniae (CPKP) is their combination with carbapenemase inhibitors. To address these issues, the effectiveness of a novel combinatio...

(This article belongs to the Special Issue New Approaches to Fighting Infectious Diseases: Overcoming the Antimicrobial Resistance in Current Treatments)
  • Feature Paper
  • Article
  • Open Access
1 Citations
1,990 Views
12 Pages

Hollow Fiber Microreactor Combined with Digital Twin to Optimize the Antimicrobial Evaluation Process

  • Kazuhiro Noda,
  • Toshihiro Kasama,
  • Marie Shinohara,
  • Masakaze Hamada and ,
  • Yukiko T. Matsunaga,
  • Madoka Takai,
  • Yoshikazu Ishii and
  • Ryo Miyake
  • + 3 authors+ 0 author

20 December 2024

In order to reproduce pharmacokinetics (PK) profiles seen in vivo, the Hollow Fiber Infection Model (HFIM) is a useful in vitro module in the evaluation of antimicrobial resistance. In order to reduce the consumption of culture medium and drugs, we d...

(This article belongs to the Section C: Chemistry)
  • Article
  • Open Access
1 Citations
1,706 Views
12 Pages

Resensitizing the Untreatable: Zidovudine and Polymyxin Combinations to Combat Pan-Drug-Resistant Klebsiella pneumoniae

  • Jan Naseer Kaur,
  • Jack F. Klem,
  • Gebremedhin S. Hailu,
  • Nader N. Nasief and ,
  • Yang Liu,
  • Allison Hanna,
  • Albert Chen,
  • Patricia Holden,
  • Shivali Kapoor and
  • Brian T. Tsuji
  • + 8 authors+ 3 authors

11 October 2025

Background: The emergence of pan-drug-resistant (PDR) Klebsiella pneumoniae has compromised the efficacy of last-line agents, leaving few therapeutic options. Repurposing zidovudine, an FDA-approved thymidine analog with antibacterial activity, may e...

(This article belongs to the Section Pharmacology)
  • Review
  • Open Access
40 Citations
7,711 Views
13 Pages

Polymyxins: To Combine or Not to Combine?

  • Federico Perez,
  • Nadim G. El Chakhtoura,
  • Mohamad Yasmin and
  • Robert A. Bonomo

Polymyxins have been a mainstay for the treatment of extensively drug resistant (XDR) Gram-negative bacteria for the past two decades. Many questions regarding the clinical use of polymyxins have been answered, but whether the administration of polym...

(This article belongs to the Special Issue Proceedings from the 3rd International Conference on Polymyxins)
  • Article
  • Open Access
7 Citations
3,706 Views
13 Pages

22 January 2020

Toxins produced by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) contribute to virulence. We developed a statistical approach to determine an optimum sequence of antimicrobials to treat CA-MRSA infections based on an anti...

(This article belongs to the Special Issue Staphylococcus aureus Toxins: Promoter or Handicap during Infection)